Spanish Ebola Patient Gets Experimental Drug
AP Photo/ Michael Duff
A Health Ministry statement Monday said the ZMapp drug, made by Mapp Biopharmaceutical Inc. of San Diego, was obtained in Geneva this weekend and brought to Madrid to treat Miguel Pajares.
Two Americans diagnosed with Ebola in Liberia recently have been treated with the drug and are said to be improving.
There is no known cure for Ebola and more than 1,000 people have died in the current outbreak in West Africa.
Pajares, 75, was evacuated from Liberia and placed in isolation Thursday in Madrid's Carlos III hospital.
- Glenmark to divest 75% stake in Glenmark Life Sciences to Nirma; stock slips
- Families concerned over 'escalating tension' between India and Canada
- India-Canada tension: Trudeau says not looking to provoke; MEA says no specific information shared
- HDFC MF gets Reserve Bank nod for raising stake in Federal Bank, Equitas SFB to 9.5%
- Cutting across party lines, Rajya Sabha MPs support women's reservation bill